These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 14232196)
1. SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT. MASSEY LW Can Med Assoc J; 1965 Jan; 92(4):186-7. PubMed ID: 14232196 [No Abstract] [Full Text] [Related]
2. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. GREINER AC; BERRY K Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375 [TBL] [Abstract][Full Text] [Related]
3. LENS AND CORENEA CHANGES DURING PHENOTHIAZINE THERAPY: A PRELIMINARY REPORT. BARSA JA; NEWTON JC; SAUNDERS JC Am J Psychiatry; 1965 Sep; 122():331-2. PubMed ID: 14327480 [No Abstract] [Full Text] [Related]
4. PIGMENT DEPOSITION IN VISCERA ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY. GREINER AC; NICOLSON GA Can Med Assoc J; 1964 Sep; 91(12):627-35. PubMed ID: 14201249 [TBL] [Abstract][Full Text] [Related]
5. 7-HYDROXYCHLORPROMAZINE: POTENTIAL TOXIC DRUG METABOLITE IN PSYCHIATRIC PATIENTS. PERRY TL; CULLING CF; BERRY K; HANSEN S Science; 1964 Oct; 146(3640):81-3. PubMed ID: 14173037 [TBL] [Abstract][Full Text] [Related]
6. A CLINICAL STUDY OF PIGMENTARY CHANGE IN CORNEA AND LENS IN CHRONIC CHLORPROMAZINE THERAPY. WETTERHOLM DH; SNOW HL; WINTER FC Arch Ophthalmol; 1965 Jul; 74():55-6. PubMed ID: 14303344 [No Abstract] [Full Text] [Related]
7. LENTICULAR AND CORNEAL OPACITIES DURING PHENOTHIAZINE THERAPY. BARSA JA; NEWTON JC; SAUNDERS JC JAMA; 1965 Jul; 193():10-2. PubMed ID: 14297702 [No Abstract] [Full Text] [Related]
8. SKIN PIGMENTATION, A RARE SIDE EFFECT OF CHLORPROMAZINE. BAN TA; LEHMANN HE Can Psychiatr Assoc J; 1965 Apr; 10():112-24. PubMed ID: 14286163 [No Abstract] [Full Text] [Related]
9. DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY. FELDMAN PE; FRIERSON BD Am J Psychiatry; 1964 Aug; 121():187-8. PubMed ID: 14194222 [No Abstract] [Full Text] [Related]
10. Chlorpromazine-induced skin pigmentation with corneal and lens opacities. Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137 [TBL] [Abstract][Full Text] [Related]
11. NEW SIDE EFFECTS IN PROLONGED CHLORPROMAZINE THERAPY. GREINER AC; NICOLSON GA Can Psychiatr Assoc J; 1965 Apr; 10():109-11. PubMed ID: 14286162 [No Abstract] [Full Text] [Related]
12. THE INCIDENCE AND MANAGEMENT OF CHLORPROMAZINE--SKIN-EYE SYNDROME. TREDICI LM; SCHIELE BC; MCCLANAHAN WS Minn Med; 1965 May; 48():569-74. PubMed ID: 14274411 [No Abstract] [Full Text] [Related]
13. THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT. GREINER AC; NICOLSON GA; BAKER RA Can Med Assoc J; 1964 Sep; 91(12):636-8. PubMed ID: 14201250 [TBL] [Abstract][Full Text] [Related]
14. [RELATION BETWEEN PHOTOSENSITIVITY AND PATHOLOGIC PIGMENTATION OF THE SKIN WITH HIGH DOSES OF CHLORPROMAZINE]. BAN TA; LEHMANN HE; GALLAI Z; WARNES H; LEE H Union Med Can; 1965 Mar; 94():305-7. PubMed ID: 14331395 [No Abstract] [Full Text] [Related]
19. OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE. CAIRNS RJ; CAPOORE HS; GREGORY ID Lancet; 1965 Jan; 1(7379):239-41. PubMed ID: 14238066 [No Abstract] [Full Text] [Related]
20. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472 [No Abstract] [Full Text] [Related] [Next] [New Search]